Maspons Pediatric Gastro

El Paso, Texas 79902

1 studies enrolling now · 4 studies all time

What they study most

Gastroesophageal Reflux Disease, Irritable Bowel Syndrome With Constipation (IBS-C)

Studies at this site

• Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years — Running, not enrolling
• Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C — Enrolling by invitation
• 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs — Running, not enrolling
• A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease — Completed